![Taku Nakahara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Taku Nakahara
Fondateur chez
Metagen Therapeutics, Inc.
Profil
Taku Nakahara is the founder of Metagen Therapeutics, Inc., founded in 2020, and holds the titles of President, CEO & Representative Director.
Former jobs include Venture Partner at Fast Track Initiative Inc from 2019 to 2022.
Education history includes a doctorate from Hokkaido University conferred in 2006 and an MBA from Rutgers Business School conferred in 2014.
Postes actifs de Taku Nakahara
| Sociétés | Poste | Début |
|---|---|---|
Metagen Therapeutics, Inc.
 Metagen Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides medical and drug discovery services to patients | Fondateur | 01/01/2020 |
Anciens postes connus de Taku Nakahara
| Sociétés | Poste | Fin |
|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Private Equity Investor | 31/05/2022 |
Formation de Taku Nakahara
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Hokkaido University
 Hokkaido University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Finance |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Metagen Therapeutics, Inc.
Metagen Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides medical and drug discovery services to patients | Health Services |
Choisissez Zonebourse 
